A series of nitrocoumarin and nitrochromene derivatives have been prepared and shown to inhibit the phosphatidylinositol-specific phospholipase C(PLC)(IC50 < 10 mu g/mL) isolated from human melanoma. The inhibition of PLC by nitrocoumarin 4a was time-dependent and irreversible. The inhibition of PLC was shown to interfere with inositide metabolism in whole cells (IC50 = 4 mu g/mL) in a manner consistent with their proposed mode of activity, Finally, the compounds were shown to be growth inhibitory to cultured melanoma cells (ID50 = 2 mu g/ML), suggesting that PLC may be an attractive new target for chemotherapeutic intervention.
Perrella Frank W., Chen Shih-Fong, Behrens Davette L., Kaltenbach Robert +, J. Med. Chem, 37 (1994) N 14, S 2232-2237
作者:Perrella Frank W., Chen Shih-Fong, Behrens Davette L., Kaltenbach Robert +
DOI:——
日期:——
RENE, L.;ROYER, R., EUR. J. MED. CHEM.-CHIM. THER., 1982, 17, N 1, 89-90
作者:RENE, L.、ROYER, R.
DOI:——
日期:——
Phospholipase C Inhibitors: A New Class of Agents
作者:Frank W. Perrella、Shih-Fong Chen、Davette L. Behrens、Robert F. III Kaltenbach、Steven P. Seitz
DOI:10.1021/jm00040a016
日期:1994.7
A series of nitrocoumarin and nitrochromene derivatives have been prepared and shown to inhibit the phosphatidylinositol-specific phospholipase C(PLC)(IC50 < 10 mu g/mL) isolated from human melanoma. The inhibition of PLC by nitrocoumarin 4a was time-dependent and irreversible. The inhibition of PLC was shown to interfere with inositide metabolism in whole cells (IC50 = 4 mu g/mL) in a manner consistent with their proposed mode of activity, Finally, the compounds were shown to be growth inhibitory to cultured melanoma cells (ID50 = 2 mu g/ML), suggesting that PLC may be an attractive new target for chemotherapeutic intervention.
Rene; Royer, European Journal of Medicinal Chemistry, 1982, vol. 17, # 1, p. 89 - 90